Brief: Castle Biosciences Q4 Revenue USD 86.311 Million Vs. IBES Estimate USD 81.9 Million
27/02/2025 21:05
Feb 27 (Reuters) - Castle Biosciences Q4 operating income USD 4.05 million. Q4 net income USD 9.59 million vs. IBES estimate USD 1.18 million Q4 pretax profit USD 7.885 million vs. IBES estimate USD 2.92 million Q4 operating expenses USD 82.261 million
Recent news on Castle Biosciences
See all newsBrief: Castle Biosciences, - Opens New Laboratory And Office Facility In Scottsdale, Arizona
U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Castle Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Castle Biosciences beats Q2 revenue estimates, hikes forecast
Brief: Castle Biosciences Q2 Revenue USD 103.546 Million Vs. IBES Estimate USD 86.2 Million